The pharmaceutical industry is actively incorporating artificial intelligence (AI) across various stages, including drug discovery, development, and clinical trials. AstraZeneca has distinguished itself in the realm of clinical trials by deploying AI technology at an unprecedented public health scale.
While competitors primarily focus on optimizing internal research and development (R&D) pipelines, AstraZeneca's AI is already integrated into national healthcare systems. This technology reportedly screens hundreds of thousands of patients, demonstrating AI's tangible impact on patients and the broader healthcare system.